Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell transplantation for ischemic stroke.

Nirav Vora1, Tudor Jovin, Douglas Kondziolka

  • 1University of Pittsburgh Medical Center Stroke Institute, Department of Neurosurgery, Pittsburgh, PA 15213, USA.

Neuro-Degenerative Diseases
|August 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Imaging Outcomes After Trigeminal Schwannoma Radiosurgery: Results From a Multicenter, International Cohort Study.

Neurosurgery·2023
Same author

Epilepsy associated with cerebral cavernous malformations managed with stereotactic radiosurgery: an international, multicenter study.

Journal of neurology·2023
Same author

Carbon fiber-reinforced PEEK spinal implants for primary and metastatic spine tumors: a systematic review on implant complications and radiotherapy benefits.

Journal of neurosurgery. Spine·2023
Same author

Stratifying Risk of Future Growth Among Sporadic Vestibular Schwannomas.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2023
Same author

Outcome Evaluation of Repeat Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations.

Stroke·2023
Same author

Developing an Automated Registry (Autoregistry) of Spine Surgery Using Natural Language Processing and Health System Scale Databases.

Neurosurgery·2023
Same journal

Just Semantics? How Diagnostic Criteria Influence Physician-Patient Narratives in Alzheimer's Disease.

Neuro-degenerative diseases·2026
Same journal

Hearing Loss as a Potentially Modifiable Marker of Dementia Risk: Neurological Evidence, Uncertainty, and Clinical Interpretation.

Neuro-degenerative diseases·2026
Same journal

Predictors of Incident Dementia in a Cohort of Elders with Essential Tremor: A Prospective, Longitudinal Study.

Neuro-degenerative diseases·2026
Same journal

Cognitive impairment is associated with disrupted motor planning in older adults.

Neuro-degenerative diseases·2026
Same journal

Beyond the Leak: Advanced MRI Assessment of the Blood-Brain Barrier in Neurodegeneration.

Neuro-degenerative diseases·2026
Same journal

The Utility of Speech and Language Analytics for Screening Alzheimer's Disease.

Neuro-degenerative diseases·2026
See all related articles

Cell replacement therapy shows promise for stroke recovery. Early human studies indicate safety and potential benefits, but more research is needed to confirm efficacy and optimize treatment.

Area of Science:

  • Regenerative medicine
  • Neuroscience
  • Neurology

Background:

  • Ischemic stroke causes fixed neurologic deficits.
  • Cell replacement therapy is a potential regenerative strategy.
  • Animal models show promise for specific cell lines in stroke recovery.

Purpose of the Study:

  • Evaluate cell replacement therapy for stroke.
  • Assess safety and pilot efficacy in humans.
  • Understand mechanisms and optimize treatment.

Main Methods:

  • Pilot studies in human patients.
  • Implantation of specific cell lines into ischemic injury areas.

Main Results:

  • Promising early results regarding safety and efficacy.

Related Experiment Videos

  • Observed improvements in behavior and motor function in animal models.

    • Conclusions:

    • Cell replacement therapy is a promising regenerative strategy for stroke.
    • Further prospective trials are essential to demonstrate clinical efficacy.
    • Need to understand mechanisms, patient selection, and optimal delivery for cell therapy.